FDA to miss PDUFA date on Zogenix's painkiller; Hyperion out to raise $50M;

 @FierceBiotech: From FierceVaccines.com: Is it too soon to quit on Nabi's nicotine vaccine? More | Follow @FierceBiotech

@JohnCFierce: Optimer shares spiking with CEO turned out and the board looking for a buyer. Release | Follow @JohnCFierce

@RyanMFierce: What Facebook and Google billionaires could do for overlooked biotech brains. Item | Follow @RyanMFierce

> The FDA will likely miss its March 1 deadline to decide on the fate of Zogenix's ($ZGNX) painkiller Zohydro. Report

> Just weeks after winning an approval for Ravicti, Hyperion Therapeutics is out to raise $50 million in a public offering. Story

> Higher R&D costs at Bio-Rad has weighed heavily on its profits. Report

Pharma News

@FiercePharma: Allergan settles Botox case in OK. Article | Follow @FiercePharma

@EricPFierce: AstraZeneca manager accused of getting home makeover at the company's cost. Sunroom, new kitchen, bathroom fixtures. Story | Follow @EricPFierce

> Hospira issues three recalls as it faces crucial FDA inspection. Item

> FDA halts pediatric study of Amgen's Sensipar after death. Story

> India may kill compulsory licensing based on price. More

Medical Device News

 @FierceMedDev: Work advances on early-detection ovarian cancer blood Dx. Story | Follow @FierceMedDev

 @MarkHFierce: J&J faces possible punitive damages in the first verdict regarding faulty vaginal mesh. Thousands of cases to come. Report | Follow @MarkHFierce

 @DamianFierce: The device industry is urging lawmakers to settle on a budget and, of course, repeal the device tax. Article | Follow @DamianFierce

> Quotient draws another $5M for transfusion Dx development. Story

> France's SpineGuard wins Russian nod for wireless spine surgery tool. Item

> Devicemakers: Excise tax, budget battle could cripple industry. Article

Drug Delivery News

@MichaelGFierce: Sanofi's Genzyme hits target with muscular dystrophy RNA drug in mice. Article | Follow @MichaelGFierce

> Ocular Therapeutix submits cataract-surgery sealant for FDA approval. Story

> Synthetic protein tricks immune system for drug delivery, device safety. News

> SHL ups Taiwanese auto injector production by $40M. More

And Finally… The spread of drug-resistant strains of gonorrhea has caused the number of new cases to spike in the U.K. Story

 

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.